[go: up one dir, main page]

TR201720406A2 - Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar - Google Patents

Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar Download PDF

Info

Publication number
TR201720406A2
TR201720406A2 TR2017/20406A TR201720406A TR201720406A2 TR 201720406 A2 TR201720406 A2 TR 201720406A2 TR 2017/20406 A TR2017/20406 A TR 2017/20406A TR 201720406 A TR201720406 A TR 201720406A TR 201720406 A2 TR201720406 A2 TR 201720406A2
Authority
TR
Turkey
Prior art keywords
multiple sclerosis
skeletal muscle
loaer
combinations containing
sclerosis therapy
Prior art date
Application number
TR2017/20406A
Other languages
English (en)
Inventor
Palantöken Arzu
Zengi̇ner Si̇bel
Türkyilmaz Ali̇
Pehli̇van Akalin Nur
Tuncay Emi̇ne
Peker Merve
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/20406A priority Critical patent/TR201720406A2/tr
Priority to PCT/TR2018/050800 priority patent/WO2019203752A2/en
Priority to EP18915063.4A priority patent/EP3723755A4/en
Publication of TR201720406A2 publication Critical patent/TR201720406A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, en az bir iskelet kası gevşetici ajan ve en az bir multipl skleroz tedavi edici ajan içeren kombinasyonlarla ilgilidir.
TR2017/20406A 2017-12-14 2017-12-14 Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar TR201720406A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/20406A TR201720406A2 (tr) 2017-12-14 2017-12-14 Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar
PCT/TR2018/050800 WO2019203752A2 (en) 2017-12-14 2018-12-12 Combinations comprising a skeletal muscle relaxant agent and a multiple sclerosis treating agent
EP18915063.4A EP3723755A4 (en) 2017-12-14 2018-12-12 COMBINATIONS INCLUDING A SKELETAL MUSCLE RELAXATION AGENT AND A MULTIPLE SCLEROSIS TREATMENT AGENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/20406A TR201720406A2 (tr) 2017-12-14 2017-12-14 Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar

Publications (1)

Publication Number Publication Date
TR201720406A2 true TR201720406A2 (tr) 2019-07-22

Family

ID=67900478

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/20406A TR201720406A2 (tr) 2017-12-14 2017-12-14 Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar

Country Status (3)

Country Link
EP (1) EP3723755A4 (tr)
TR (1) TR201720406A2 (tr)
WO (1) WO2019203752A2 (tr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117161A1 (en) * 2018-12-07 2020-06-11 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A combination comprising dimethyl fumarate and at least one muscle relaxant agent
WO2020139238A3 (en) * 2018-12-28 2020-07-30 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations comprising fingolimod and a spasmolytic

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201819202A2 (tr) * 2018-12-12 2020-06-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon
JP7503420B2 (ja) * 2020-05-18 2024-06-20 東和薬品株式会社 フィンゴリモドを含む医薬組成物とその製造方法及び安定化方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3215132B1 (en) 2014-11-04 2021-01-27 Adamas Pharmaceuticals, Inc. Amantadine for improving gait in multiple sclerosis
WO2017031276A1 (en) * 2015-08-19 2017-02-23 The Regents Of The University Of California Methods of providing neuroprotective therapy related to administering an estrogen receptor beta ligand

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117161A1 (en) * 2018-12-07 2020-06-11 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A combination comprising dimethyl fumarate and at least one muscle relaxant agent
WO2020139238A3 (en) * 2018-12-28 2020-07-30 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations comprising fingolimod and a spasmolytic

Also Published As

Publication number Publication date
EP3723755A4 (en) 2021-09-15
EP3723755A2 (en) 2020-10-21
WO2019203752A2 (en) 2019-10-24
WO2019203752A3 (en) 2020-01-16

Similar Documents

Publication Publication Date Title
IL280536A (en) Muscle targeting complexes and uses thereof
PH12020550622A1 (en) Kras g12c inhibitors
MX378273B (es) Compuestos activos hacia bromodominios.
MX2019003938A (es) Compuestos espirociclicos.
ZA201807518B (en) Benzenesulfonamide compounds and their use as therapeutic agents
EA201991997A1 (ru) Комбинированная терапия
MX2019011945A (es) Terapia de combinacion contra cancer.
IL267143A (en) Benzenesulfonamide compounds and their use as therapeutic agents
TR201720406A2 (tr) Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar
IL278949A (en) Benzene sulfonamide compounds and their use as medicinal agents
BR112018000217A2 (pt) sistemas de distribuição de nanopartículas aperfeiçoados
EA201990567A1 (ru) Комбинированная терапия с ингибиторами глутаминазы
MX379622B (es) Compuestos espirociclicos
MX2017014436A (es) Compuestos biciclicos.
AU201810263S (en) Soap Bar
MX2020005483A (es) Antagonistas de ildr2 y combinaciones de los mismos.
JO3456B1 (ar) فيروتيوكسيتين بيروجلوتامات
WO2016130581A3 (en) Combination cancer therapy
MX2017012610A (es) Composiciones y metodos para inhibir la expresion del gen lect2.
MX2017006513A (es) Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor.
MX2019002901A (es) Tratamiento de esclerosis multiple con chs-131.
GB2564990A (en) Topical compositions for neuropathic pain
MX2020002886A (es) Agente profilactico y/o terapeutico para enfermedades que involucran la expresion de ido.
CY1122708T1 (el) Ενωσεις οξα-διαζασπειρο με δραση εναντι του πονου
NZ755501A (en) Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same